SAB Biotherapeutics (SABS) EPS (Diluted) (2020 - 2026)
SAB Biotherapeutics' EPS (Diluted) was -$0.28 in Q2 2026, compared with -$1.09 a year earlier.
Powered by 
Analysis
SAB Biotherapeutics (SABS) EPS (Diluted) (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, SAB Biotherapeutics' EPS (Diluted) was -$0.16 through Jun 30, 2026; for FY2025, it came in at $0.22.
- EPS (Diluted) shows a five-year compound annual growth rate of -50.7% (FY2020 to FY2025).
- In earlier years, EPS (Diluted) was -$3.68 in FY2024, -$7.64 in FY2023, -$4.31 in FY2022 and -$6.27 in FY2021.
- Quarterly EPS (Diluted) has moved between -$4.23 (Q4 2021) and $0.58 (Q3 2025) over five years.
- Per Business Quant data, SABS's EPS (Diluted) in the three quarters before Q2 2026 was -$0.35 (Q1 2026), -$0.27 (Q4 2025) and $0.58 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 7.22 |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 0.09 |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 2.38 |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.04 |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 2.00 |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 7.08 |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.94 |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 0.56 |
| 10 | SAB Biotherapeutics | 279.79 Mn | -130.87 Mn | - | -0.29 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -0.29 |
| Jun 30, 2026 | -0.28 |
| Mar 31, 2026 | -0.35 |
| Dec 31, 2025 | -0.27 |
| Sep 30, 2025 | 0.58 |
| Jun 30, 2025 | -1.09 |
| Mar 31, 2025 | -0.56 |
| Dec 31, 2024 | -1.23 |
| Sep 30, 2024 | -1.12 |
| Jun 30, 2024 | -0.79 |
| Mar 31, 2024 | -0.54 |
| Dec 31, 2023 | -4.14 |
| Sep 30, 2023 | -0.97 |
| Jun 30, 2023 | -1.36 |
| Mar 31, 2023 | -1.46 |
| Dec 31, 2022 | -1.81 |
| Sep 30, 2022 | -1.64 |
| Jun 30, 2022 | -1.11 |
| Mar 31, 2022 | 0.22 |
| Dec 31, 2021 | -4.23 |
API Access
SAB Biotherapeutics EPS (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=eps-diluted&ticker=SABS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "eps-diluted", "ticker": "SABS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=eps-diluted&ticker=SABS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();